AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.610
0.00 (0.00%)
Jul 24, 2026, 4:00 PM EDT - Market closed
AVITA Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Buy" and an average price target of $9.07. The average 1-year stock price forecast is 96.75% higher than the current stock price, while the lowest is $6.00 (+30.15%) and the highest is $12.14 (+163.34%).
Price Target: $9.07 (+96.75%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jul 21, 2026 |
| Lake Street | Lake Street | Buy Reiterates $6 | Buy | Reiterates | $6 | +30.15% | Jul 16, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $5.5 → $12 | Buy | Maintains | $5.5 → $12 | +160.30% | Jun 30, 2026 |
| Northland Securities | Northland Securities | Buy Maintains $10 | Buy | Maintains | $10 | +116.92% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
83.86M
from 71.61M
Increased by 17.11%
Revenue Next Year
107.70M
from 83.86M
Increased by 28.42%
EPS This Year
-1.03
from -1.74
EPS Next Year
-0.60
from -1.03
EPS and Forward PE are based on non-GAAP adjusted numbers.